331 – 340 of 466
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Rationale and Design of the 'MITOCARE' Study: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of TRO40303 for the Reduction of Reperfusion Injury in Patients Undergoing Percutaneous Coronary Intervention for Acute Myocardial Infarction
(
- Contribution to journal › Article
-
Mark
TRITON and Beyond: New Insights into the Profile of Prasugrel.
(
- Contribution to journal › Article
-
Mark
The touching story of purinergic signaling in epithelial and endothelial cells.
(
- Contribution to journal › Article
-
Mark
Quantification of myocardium at risk in myocardial perfusion SPECT by co-registration and fusion with delayed contrast-enhanced magnetic resonance imaging - an experimental ex vivo study.
(
- Contribution to journal › Article
-
Mark
Plasma Levels of Liver-Specific miR-122 is Massively Increased in a Porcine Cardiogenic Shock Model and Attenuated by Hypothermia.
(
- Contribution to journal › Article
-
Mark
Ticagrelor induces adenosine triphosphate release from human red blood cells.
(
- Contribution to journal › Article
-
Mark
A Common Missense Variant in the ATP Receptor P2X7 Is Associated with Reduced Risk of Cardiovascular Events.
(
- Contribution to journal › Article
-
Mark
Farnesyl pyrophosphate is an endogenous antagonist to ADP-stimulated P2Y12 receptor-mediated platelet aggregation.
(
- Contribution to journal › Article
-
Mark
P2X7 receptor inhibition attenuates human macrophage response to oxidized low-density lipoprotein
2012) 61th Annual Scientific Session of the American College of Cardiology and i2 Summit: Innovation in Intervention, ACC.12(
- Contribution to conference › Abstract
- 2011
-
Mark
Hypothermia in cardiogenic shock reduces systemic t-PA release.
(
- Contribution to journal › Article